5-hydroxytryptophan has been researched along with Kallmann Syndrome in 1 studies
5-Hydroxytryptophan: The immediate precursor in the biosynthesis of SEROTONIN from tryptophan. It is used as an antiepileptic and antidepressant.
5-hydroxytryptophan : A tryptophan derivative that is tryptophan substituted by a hydroxy group at position 5.
Kallmann Syndrome: A genetically heterogeneous disorder caused by hypothalamic GNRH deficiency and OLFACTORY NERVE defects. It is characterized by congenital HYPOGONADOTROPIC HYPOGONADISM and ANOSMIA, possibly with additional midline defects. It can be transmitted as an X-linked (GENETIC DISEASES, X-LINKED), an autosomal dominant, or an autosomal recessive trait.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lado-Abeal, J | 1 |
| Rey, C | 1 |
| Cabezas-Agricola, JM | 1 |
| Rodriguez, A | 1 |
| Camarero, E | 1 |
| Cabezas-Cerrato, J | 1 |
1 other study available for 5-hydroxytryptophan and Kallmann Syndrome
| Article | Year |
|---|---|
L-hydroxytryptophan amplifies pulsatile secretion of LH in the follicular phase of normal women.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Anorexia Nervosa; Benserazide; Dopamine Agents; Female; Foll | 1997 |